Clinical Trial Update: A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or Narcolepsy [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating XYWAV for sleepiness, polysomnography metrics, and functional outcomes in idiopathic hypersomnia and narcolepsy has completed. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Hypersomnia
• Narcolepsy

Drugs mentioned

• XYWAV (CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Idiopathic Hypersomnia, Narcolepsy | Phase 4 | Status: COMPLETED